共 50 条
Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)
被引:26
|作者:
Palte, Rachel L.
[1
]
Schneider, Sebastian E.
[1
]
Altman, Michael D.
[1
]
Hayes, Robert P.
[2
]
Kawamura, Shuhei
[1
]
Lacey, Brian M.
[1
]
Mansueto, My Sam
[1
]
Reutershan, Michael
[1
]
Siliphaivanh, Phieng
[1
]
Sondey, Christopher
[1
]
Xu, Haiyan
[1
]
Xu, Zangwei
[1
]
Ye, Yingchun
[1
]
Machacek, Michelle R.
[1
]
机构:
[1] Merck & Co Inc, Computat & Struct Chem, Boston, MA 02115 USA
[2] Computat & Struct Chem, West Point, PA 19486 USA
来源:
ACS MEDICINAL CHEMISTRY LETTERS
|
2020年
/
11卷
/
09期
关键词:
PRMT5;
allosteric inhibition;
methyltransferase;
peptide competitive;
SAM competitive;
crystal structure;
SELECTIVE INHIBITOR;
METHYLATION;
POTENT;
DISCOVERY;
DELETION;
HISTONE;
D O I:
10.1021/acsmedchemlett.9b00525
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Protein arginine methyltransferase 5 (PRMT5) belongs to a family of enzymes that regulate the posttranslational modification of histones and other proteins via methylation of arginine. Methylation of histones is linked to an increase in transcription and regulates a manifold of functions such as signal transduction and transcriptional regulation. PRMT5 has been shown to be upregulated in the tumor environment of several cancer types, and the inhibition of PRMT5 activity was identified as a potential way to reduce tumor growth. Previously, four different modes of PRMT5 inhibition were known-competing (covalently or non-covalently) with the essential cofactor Sadenosyl methionine (SAM), blocking the substrate binding pocket, or blocking both simultaneously. Herein we describe an unprecedented conformation of PRMT5 in which the formation of an allosteric binding pocket abrogates the enzyme's canonical binding site and present the discovery of potent small molecule allosteric PRMT5 inhibitors.
引用
收藏
页码:1688 / 1693
页数:6
相关论文